From Eurosport:
Spanish rider Iban Mayo had been targeted by the International Cycling Union as a possible offender prior to his positive test for erythropoietin during the Tour de France.
Mayo, who finished the race in 16th place, was suspended by his team Saunier Duval on Monday after cycling's governing body confirmed traces of EPO in a sample taken on the July 24 rest day.
"It's another sad episode in the Tour de France," UCI president Pat McQuaid said. "People need to understand, the riders need to understand that that the UCI operates in a different way than in the past. Thanks to the blood tests, we target riders.
"Iban Mayo was one of the UCI targets," he added. "The riders have to understand that we use intelligence to target some of them."
EPO is a blood-boosting substance that was at the centre of the Festina affair that tarnished the 1998 Tour de France.
"It is surprising that the riders still use it knowing it is detectable," MacQuaid added.
The UCI chief added that Alexander Vinokourov, who tested positive for homologous blood-doping, was probably unaware that the French laboratory used by Tour organisers had mastered detection methods for this kind of offence.
"Up to this year, only the Lausanne laboratory [in Switzerland] was conducting tests for homologous blood-doping," McQuaid said.
"But the Lausanne lab taught the French one how to detect it and therefore they were able to test Vinokourov's sample."
Spanish rider Iban Mayo had been targeted by the International Cycling Union as a possible offender prior to his positive test for erythropoietin during the Tour de France.
Mayo, who finished the race in 16th place, was suspended by his team Saunier Duval on Monday after cycling's governing body confirmed traces of EPO in a sample taken on the July 24 rest day.
"It's another sad episode in the Tour de France," UCI president Pat McQuaid said. "People need to understand, the riders need to understand that that the UCI operates in a different way than in the past. Thanks to the blood tests, we target riders.
"Iban Mayo was one of the UCI targets," he added. "The riders have to understand that we use intelligence to target some of them."
EPO is a blood-boosting substance that was at the centre of the Festina affair that tarnished the 1998 Tour de France.
"It is surprising that the riders still use it knowing it is detectable," MacQuaid added.
The UCI chief added that Alexander Vinokourov, who tested positive for homologous blood-doping, was probably unaware that the French laboratory used by Tour organisers had mastered detection methods for this kind of offence.
"Up to this year, only the Lausanne laboratory [in Switzerland] was conducting tests for homologous blood-doping," McQuaid said.
"But the Lausanne lab taught the French one how to detect it and therefore they were able to test Vinokourov's sample."